Selection of Hepatocellular Carcinoma Patients for Liver Transplantation: Should the Threshold for Expected Oncological Survival Be Lowered?
作者信息
Giacomoni Alessandro, Centonze Leonardo, Famularo Simone, Tripepi Matteo, DeCarlis Luciano
机构信息
Department of General and Transplant Surgery, Niguarda Hospital, Milano, Italy.
School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.
出版信息
Transplant Direct. 2019 May 29;5(6):e459. doi: 10.1097/TXD.0000000000000904. eCollection 2019 Jun.
Abstract
摘要
相似文献
1
Selection of Hepatocellular Carcinoma Patients for Liver Transplantation: Should the Threshold for Expected Oncological Survival Be Lowered?肝细胞癌患者肝移植的选择：预期肿瘤学生存的阈值是否应降低？
Transplant Direct. 2019 May 29;5(6):e459. doi: 10.1097/TXD.0000000000000904. eCollection 2019 Jun.
2
Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma in Hong Kong.香港乙型肝炎病毒相关肝细胞癌的肝移植
J Clin Transl Hepatol. 2018 Sep 28;6(3):283-288. doi: 10.14218/JCTH.2017.00058. Epub 2018 Apr 5.
3
[Hepatocellular carcinoma: impact of waiting list and pre-operative treatment strategies on survival of cadaveric liver transplantation in pre-MELD era in one center in Brazil].[肝细胞癌：在巴西一个中心的MELD时代之前，等待名单和术前治疗策略对尸体肝移植患者生存的影响]
Arq Gastroenterol. 2007 Jul-Sep;44(3):189-94. doi: 10.1590/s0004-28032007000300002.
4
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.预测米兰标准以外的肝细胞癌患者肝移植后的生存率：一项回顾性探索性分析。
Lancet Oncol. 2009 Jan;10(1):35-43. doi: 10.1016/S1470-2045(08)70284-5. Epub 2008 Dec 4.
5
Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.ABO 不相容成人活体肝移植治疗肝细胞癌患者的结局。
J Hepatol. 2018 Jun;68(6):1153-1162. doi: 10.1016/j.jhep.2018.02.002. Epub 2018 Feb 13.
6
[Results of liver transplantation in patients with hepatocellular carcinoma].[肝细胞癌患者肝移植的结果]
Arq Gastroenterol. 2001 Oct-Dec;38(4):216-20. doi: 10.1590/s0004-28032001000400002.
7
Indications and Role of Liver Transplantation for Malignant Tumors.肝脏移植治疗恶性肿瘤的适应证及作用
Oncologist. 1997;2(3):164-170.
8
Addition of alfa fetoprotein to traditional criteria for hepatocellular carcinoma improves selection accuracy in liver transplantation.将甲胎蛋白添加到肝细胞癌的传统标准中可提高肝移植的选择准确性。
Scand J Gastroenterol. 2018 Aug;53(8):976-983. doi: 10.1080/00365521.2018.1488180. Epub 2018 Aug 31.
9
[Selection criteria for liver transplantation recipients of hepatocellular carcinoma].[肝细胞癌肝移植受者的选择标准]
Zhonghua Gan Zang Bing Za Zhi. 2018 Feb 20;26(2):84-87. doi: 10.3760/cma.j.issn.1007-3418.2018.02.002.
10
The role of preoperative albumin-bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma.术前白蛋白-胆红素分级在肝癌肝移植患者中的肿瘤风险分层作用。
J Surg Oncol. 2019 Dec;120(7):1126-1136. doi: 10.1002/jso.25721. Epub 2019 Oct 2.
本文引用的文献
1
Outcome of Liver Transplant Patients With High Urgent Priority: Are We Doing the Right Thing?高紧急优先级肝移植患者的结局：我们做的对吗？
Transplantation. 2019 Jun;103(6):1181-1190. doi: 10.1097/TP.0000000000002526.
2
What is transplant oncology?什么是移植肿瘤学？
Surgery. 2019 Feb;165(2):281-285. doi: 10.1016/j.surg.2018.10.024. Epub 2018 Nov 22.
3
Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Paradigms for Resectable Disease in Annals of Surgery 2018.肝门部胆管癌的移植与切除术：《外科学年鉴》2018年中关于可切除疾病治疗模式转变的观点
Ann Surg. 2018 May;267(5):808-809. doi: 10.1097/SLA.0000000000002716.
4
Pro (With Caution): Extended oncologic indications in liver transplantation.慎重推荐：肝移植的扩展肿瘤适应证。
Liver Transpl. 2018 Jan;24(1):98-103. doi: 10.1002/lt.24963. Epub 2017 Dec 8.
5
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.Metroticket 2.0 模型分析肝癌肝移植术后死亡的竞争风险。
Gastroenterology. 2018 Jan;154(1):128-139. doi: 10.1053/j.gastro.2017.09.025. Epub 2017 Oct 5.
6
Liver transplantation for unresectable colorectal liver metastases: A systematic review.不可切除的结直肠癌肝转移的肝移植：一项系统评价。
J Surg Oncol. 2017 Sep;116(3):288-297. doi: 10.1002/jso.24671. Epub 2017 May 17.
7
Change of liver transplantation list composition: Pre versus post direct-acting antivirals era. The Niguarda Hospital experience.肝移植等待名单构成的变化：直接抗病毒药物时代之前与之后。尼瓜尔达医院的经验。
Dig Liver Dis. 2017 Mar;49(3):317. doi: 10.1016/j.dld.2017.01.145. Epub 2017 Jan 19.
8
Living donor liver transplantation for hepatocellular carcinoma in Seoul National University.首尔国立大学肝细胞癌活体供肝移植术
Hepatobiliary Surg Nutr. 2016 Dec;5(6):453-460. doi: 10.21037/hbsn.2016.08.07.
9
Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.直接抗病毒治疗时代肝移植等待名单的减少
Hepatology. 2017 Mar;65(3):804-812. doi: 10.1002/hep.28923. Epub 2016 Dec 24.
10
Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.用于肝胆恶性肿瘤的肝移植：“移植肿瘤学”的新时代已经开启。
Surg Today. 2017 Apr;47(4):403-415. doi: 10.1007/s00595-016-1337-1. Epub 2016 Apr 29.
Zotero 插件